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Efficacy of a selective and differential medium 
for isolating Coryne bacterium urea ly ti cum from 
urine specimens 
Moises Garcia-Bravo’, Jose Maria Aguado’, Jose Maria Morales3 and 
Antonio R. Noriega’ 
‘Department of Microbiology, 21nfectious Diseases Unit, and 3Department of Nephrology, Hospital 
‘Doce de Octubre’, Madrid, Spain 
Objective: To describe a new selective and differential medium for improving the isolation of Corynebacterium 
urealyticum from urine. 
Methods: A total of 370 urine specimens, 270 from patients with underlying urologic disease and 100 from to a control 
group without renal pathology, were cultured on standard sheep blood agar medium and on a new selective medium 
for Corynebacterium urealyticum. 
Results: The use of this selective medium resulted in a nine-fold increase in the prevalence of bacteriuria caused by 
C. urealyticum (12.4% versus 1.4%). Furthermore, the frequency of patients with symptomatic bacteriuria detected with 
the selective medium (3.2%) was higher than with the non-selective medium (1.4%). 
Conclusions: We recommend the use of this selective medium for the isolation of C. urealyticum in patients with 
underlying urologic disease or with chronic urinary symptoms. 
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Corynebacterium urealyticum, formerly Corynebacterium 
group D2, is a Gram-positive, aerobic, non-spore- 
forming bacillus, with an intense urease activity that 
favors the formation of struvite stones (magnesium 
ammonium phosphate) in the urine, and produces 
infections of the lower urinary tract (acute and chronic 
cystitis) and of the upper tract [l]. This microorganism 
grows on blood agar, but it may not be detected using 
routine 24-11 cultures of urine specimens, due to its 
fastidious nature and the rapid overgrowth by other 
bacteria [2]. In 1991, De  Brie1 et al [2] described the 
utility of a selective culture medium in hospitalized 
patients. More recently, Mufioz et a1 [3] developed 
another selective medium with different antibiotic 
composition and including urea to permit recognition 
of the presence of urea-splitting microorganisms. How- 
ever, the yield of this medium was similar to that of 
sheep blood agar in patients with suspicion of urinary 
tract infection. 
OBJECTIVE 
The objective of this prospective study was to evaluate 
the eficacy of a new selective and differential medium 
for the isolation of C. urealyticum from urine samples 
from patients with underlying urologic diseases. 
M ETH 0 D S 
In total, 370 urine samples were obtained sequentially 
from 370 adults (186 females and 184 males, mean age 
48.7k14.6 years) by the clean catch method (329 
samples) or through urinary catheters (41 samples). Of  
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these patients, 270 had an underlying renal disease 
(renal transplant 163, chronic renal failure 57, renal 
lithiasis 50) and 100 had no underlying renal disease (50 
ambulatory patients with essential arterial hypertension 
without renal disease, and 50 healthy sanitary workers). 
A second urine specimen was always collected when C. 
urealyticum was isolated in the first sample. Specimens 
were cultured within 1 h of collection. 
A measured volume (5 pL) of urine was inoculated 
with a calibrated loop by streaking it over the entire 
surface of two standard media (5% sheep blood agar and 
MacConkey agar; ‘Biomedics’, USA), and one selective 
and differential medium of the following composition: 
heart infusion agar (40 g/L) (Difco Laboratories, 
Detroit; Michigan, USA), L-cysteine (0.128 g/L), 
urea (20 g/L), phenol red (0.01 g/L), glucose (10 g/L), 
Tween-80 (10 g/L), polymyxin B (2500 u/L), 
aztreonam (16 mg/L), fosfomycin (50 mg/L) and 
amphotericin B (2 mg/L) (final p H  6.8). The medium 
was controlled every time it was prepared by inocu- 
lating isolated colonies of several ATCC strains: C. 
urealyticum (ATCC 43042, ATCC 43043 and ATCC 
43044) as positive control, and Escherichia coli (ATCC 
25922) and Staphylococcus aureus (ATCC 29213) as 
negative controls. The three agar plates were incubated 
at 35OC in an ambient atmosphere for 72 h. Suspicious 
colonies of C. urealyticum were counted and examined 
by Gram stain. The coryneform bacteria were streaked 
on Christensen urea agar (Difco) and on 5% sheep 
blood agar. Definitive identification of a urealytic 
microorganism as C. urealyticum was performed by 
means of the API Coryne system (bioMtrieux, France) 
[4] and any number of colonies (CFU/mL) was 
considered as indicative of bacteriuria. 
Patients with C. urealyticum bacteriuria were 
evaluated clinically and classified as symptomatic or 
non-symptomatic according to the criteria reported by 
Soriano et a1 [l]. Patients were considered to have 
symptoms related to bacteriuria caused by C. 
urealyticum if they had a urethral syndrome with 
leukocyturia (at least five white blood cells per high- 
power field) or fever (238”C),  not associated with a 
different pathologic process, plus leukocyturia and at 
least two urine samples positive for C. urealyticum 
(whatever the colony count in the specimens). Patients 
with an intravesical catheter were considered sympto- 
matic if they had urethral discomfort (or an increase in 
this symptom, if it had been present previously), leuko- 
cyturia, and/or microhematuria (at least five red blood 
cells per high-power field). Patients without urinary 
symptoms were considered asymptomatic. Cystitis was 
diagnosed if the patient had symptoms of lower urinary 
tract infection (dysuria, urethral discomfort, frequency, 
urgency and vesical tenesmus) or gross hematuria 
simultaneously with the isolation of C. urealyticum from 
urine. Cystitis was arbitrarily classified as acute (symp- 
toms for <1  month) or chronic (symptoms for 21 
month). Encrusted cystitis was diagnosed cystoscopic- 
ally and defined as a chronic inflammatory lesion of the 
bladder mucosa with ulcerative zones and accumulation 
of struvite stones on the damaged bladder. Encrusted 
pyelitis was defined as the presence of struvite incrust- 
ations on the pelvis wall, observed during surgery [5]. 
Symptomatic patients were considered to have pyelo- 
nephritis if they had fever (238°C) with or without 
chills, flank pain and urinary symptoms and C. 
urealyticum was isolated exclusively from urine, or the 
patient had fever and C. urealyticum was simultaneously 
isolated from urine and blood, and there was not a 
more reasonable cause of fever. McNemarS test for 
matched pairs was used for comparison of C. urealyticum 
growth on sheep blood agar and selective medium, and 
Fisher’s test for two independent samples (symptomatic 
and asymptomatic patients). 
C. urealyticum was cultured from 47 urine samples from 
47 patients (12.7%). There were 40 females and seven 
males and the mean age was 56.9k11.7 years. The 
prevalence of bacteriuria was similar in patients with 
and without renal pathology (13% and 12%, res- 
pectively) (Table 1). However, while all the bacteriuric 
patients without underlying renal pathology (12 cases) 
were asymptomatic, in the group with underlying 
urologic disease 13 of 35 patients with bacteriuria had 
urinary symptoms (40%). Ten of these patients deve- 
loped acute cystitis, two chronic cystitis and one 
encrusted pyelitis. No patients had encrusted cystitis or 
pyelonephritis. The clinical and laboratory data on 
patients with symptomatic bacteriuria caused by C. 
urealyticum are shown in Table 2. Forty-six C. urea- 
lyticum strains (12.4%) were detected on selective 
Table 1 Bacteriuria caused by C. urealyticum 
Group 
Patients with bacteriuria (%) 
Asymptomatic Symptomatic Total 
With underlying renal 
pathology (n=270) 22 (8.2) 13 (4.8) 35 (13) 
Renal transplant (n=163) 6 (3.7) 10 (6.1) 16 (9.8) 
Chronic renal failure 
(n=57) 7 (12.3) 1 (1.7) 8 (14) 
Renal lithiasis (n=50) 9 (18) 2 (4) 11 (22) 
pathology (n= 100) 12 (12) 0 (0) 12 (12) 
Without underlying renal 
Total (n=370) 34 (9.2) 13 (3.5) 47 (12.7) 
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Table 2 Clinical and laboratory data on 13 symptomatic 
patients 
Acute Chronic Encrusted 
cystitis cystitis pyelitis 
(n=10) (n=2) ( n = l )  
Symptoms and signs 
Dysuria/urethral discomfort 
Vesical tenesnius 
Flank pain 
Suprapubic pain 
Fever 
Struvite stones 
Gross hematuria 
Ammonia-like odor of urine 
Urine characteristics 
Alkaline pH 8 2 1 
Struvite crystals 5 2 1 
Pyuria 1 0 2 1 
Microhematuria 7 2 1 
Table 3 Media evaluated for the isolation of C. urealyticum 
from 370 patients 
Number of C. urenlyticum strains isolated 
Only in sheep Only in the In both 
blood agar selective agar culture media 
Symptomatic patients 
Pure culture 
<2SX l o 4  CFU/mL 
2 2 . 5 ~ 1 0 4  C F U / ~ L  
Mixed culture 
<2.5X10t CFU/mL 
22.5X1O4 CFU/mL 
Asymptomatic patients 
Pure culture 
<2.5X104 CFU/mL 
?2.5X1O4 CFU/mL 
<2.5X lo4 CFU/mL 
22.5X104 CFU/mL 
Mixed culture 
Total 
1 
0 
1 
0 
0 
0 
0 
0 
0 
n 
1 
8 
1 
1 
0 
6" 
34 
21 
0 
11" 
2 
42 
4 
0 
4 
0 
0 
0 
0 
0 
0 
0 
4 
"TWO symptomatic patients and one asymptomatic case had 
simultaneous uririary tract infection with C. urealyticum and E. roli 
(two cases) or Pseudomorias aemginosa (one case). 
medium and five (1.4%)) on sheep blood agar (Table 3) .  
Therefore, the selective medium permitted a nine-fold 
increase in the recovery of C. urealyticum (p<O.OOl). 
Only in one patient with acute cystitis was C. 
urealyticum not detected on selective medium (two 
urine samples evaluated) while it was isolated on blood 
agar (22.5x1O4CFU/mL). On the other hand, eight 
strains from symptomatic patients were detected on 
selective medium but not on sheep blood agar. Three 
patients (two with acute cystitis and one with asynipto- 
matic infection) had simultaneous urinary tract in- 
fection by bacteria other than C. urealyticum, but none 
were urea-splitting microorganisms (two E. coli strains 
and one Pseudomonas aeruginosa strain). In these three 
patients and in another 16 cases C. urealyticum was 
detected on the selective medium but not on the 
sheep blood agar, due to overgrowth of mixed culture. 
Although the selective medium permitted the growth 
of other microorganisms (generally staphylococci and 
several coryneform species), the colonies were very 
different from those of C. urealyticum. In the selective 
medium the colonies of C. urealyticurw were visible at 
24 h, reached a diameter of 1-2 mni at 48 h, and were 
opaque, smooth, convex and yellowish. The intensity 
of the bacteriuria ranged &om 2 X lo2 to 210s CFU/mL 
(four patients). Colony counts equal to or greater than 
2.5X104 CFU/mL were more coninion in sympto- 
matic than asymptomatic patients (92.3% versus 5.9%) 
respectively, p<O.OOl). This cut-off was arbitrarily 
chosen because it allowed us a reasonable power of 
discrimination using our selective culture medium. 
CONCLUSlONS 
Better knowledge of the microbiological aspects of C. 
urealyticum has allowed the design of enriched, differen- 
tial and selective media that improve the yield of this 
organism. These media include components that stimu- 
late their growth, facilitate their identification and 
inhibit the growth of other, faster-growing bacteria. 
The selective and differential medium that we have 
evaluated contains Tween-SO, which is a detergent that 
stimulates the growth of lipophilic bacteria such as C. 
urealyticum [6].  C. urealyticum is easily identified because 
the medium detects the release of ammonia from urea, 
resulting in an increase in p H  which is shown by the 
phenol red indicator changing from yellow to pink. 
Selectivity is provided by adding four antimicrobial 
agents that inhibit the growth of other urea-splitting 
organisms. Fosfomycin and polymyxin B are employed 
to inhibit Gram-positive and Gram-negative bacteria, 
respectively. Aztreonam is included to avoid the growth 
of microorganisms resistant to polymyxin B (Proteus, 
Providencia, Morganella and, frequently, Serratia species). 
Amphotericin B is used as an antifungal agent. 
De Brie1 et a1 [2], using a selective medium, iso- 
lated C. urealyticum in 4.4% of the 5685 urine samples 
obtained from patients hospitalized in intensive care 
units and urology and oncohematology departments. 
This medium permitted an approximate eight-fold 
increase in the recovery of multiresistant corynebacteria 
(the authors evaluated C. jeikeium and C. urealyticwn 
simultaneously). Recently, several authors have also 
increased the yield of C. urealyticum by inoculation of 
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non-selected urine samples [8,9] or selected alkaline 
urine specimens (5)  on selective media. However, they 
did not recommend the use of selective media for 
routine purposes, because the prevalence of C. 
urealyticum was low (1-1.9%) and the clinical signi- 
ficance of the isolates obtained with the selective media 
was doubtful in most cases. Nevertheless, the preva- 
lence of C. tlrealyticum bacteriuria in our selected 
population, at 12.7%, was important, higher than those 
obtained by the above mentioned authors (including 
De Briel et al), and more symptomatic patients were 
detected with selective (3.2%) than with non-selective 
media (1.4%) @<0.05). Thus, we recommend the 
utilization of selective media for the isolation of C. 
urealyticum in nephrourologic patients (renal transplant, 
chronic renal failure and renal lithiasis) and in patients 
with chronic urinary symptoms, who have a higher risk 
of developing severe complications due to C. urea- 
lyticum. In asymptomatic patients the utility of the 
selective medium is unclear, because C. urealyticum is 
probably an ‘innocent’ inhabitant of the urinary tract. 
However, the patients with underlying renal disease and 
asymptomatic bacteriuria could develop severe urinary 
tract infections after urologic manipulations. These 
complications could justify the use of a selective 
medium in this population, and the prophylactic treat- 
ment of patients with underlying renal disease and 
asymptomatic bacteriuria by C. urealyticum, but further 
studies are required to confirm these speculations. 
Finally, it is important to point out that our selective 
medium is useful for performing colonization studies 
because it allows detection of many episodes of 
asymptomatic bacteriuria, with low colony counts. 
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